Syndax Pharmaceuticals Inc SEC filings

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

1. ROUTINESCHEDULE 13GSyndax Pharmaceuticals IncSNDXAug 7

   Ownership stake disclosure by STATE STREET CORP

   STATE STREET CORP, filed by

2. NOTABLE10-QSyndax Pharmaceuticals IncSNDXAug 4

   Quarterly report

3. ROUTINE8-KSyndax Pharmaceuticals IncSNDXAug 4

   Current report

4. ROUTINE8-KSyndax Pharmaceuticals IncSNDXJul 14

   Current report

5. ROUTINE4Syndax Pharmaceuticals IncSNDXJul 9

   Michael A Metzger, insider filing for SNDX

   Michael A Metzger, reporting

6. ROUTINE144Syndax Pharmaceuticals IncSNDXJul 8

   Michael A Metzger, planned sale of SNDX shares

   Michael A Metzger, reporting

7. ROUTINE4Syndax Pharmaceuticals IncSNDXJun 12

   Nicholas A.J. Botwood, insider filing for SNDX

   Nicholas A.j. Botwood, reporting

8. ROUTINE144Syndax Pharmaceuticals IncSNDXJun 12

   Nicholas A.J. Botwood, planned sale of SNDX shares

   Nicholas A.j. Botwood, reporting

9. ROUTINE144Syndax Pharmaceuticals IncSNDXJun 11

   Nicholas A.J. Botwood, planned sale of SNDX shares

   Nicholas A.j. Botwood, reporting

10. ROUTINE8-KSyndax Pharmaceuticals IncSNDXJun 10

    Current report

11. ROUTINE8-KSyndax Pharmaceuticals IncSNDXJun 10

    Current report

12. ROUTINEDEFA14ASyndax Pharmaceuticals IncSNDXJun 4

    Additional proxy materials

13. ROUTINE8-KSyndax Pharmaceuticals IncSNDXJun 4

    Current report

14. ROUTINE4Syndax Pharmaceuticals IncSNDXJun 2

    2 insider filings

    Michael A Metzger, insider filing for SNDX

    Show all 2

    • 4Insider filing for SNDXJun 2
    • 4Insider filing for SNDXJun 2

    Michael A Metzger, reporting

15. ROUTINE144Syndax Pharmaceuticals IncSNDXJun 1

    2 Form 144 notices

    Keith A. Goldan, planned sale of SNDX shares

    Show all 2

    • 144Planned insider sale of SNDX sharesJun 1
    • 144Planned insider sale of SNDX sharesJun 1

    Keith A. Goldan, reporting

16. ROUTINESCHEDULE 13G/ASyndax Pharmaceuticals IncSNDXMay 15

    Ownership stake disclosure by Point72 Asset Management, L.P. (amended)

    Point72 Asset Management, L.P., filed by

17. ROUTINEARSSyndax Pharmaceuticals IncSNDXApr 30

    Annual report to shareholders

18. ROUTINEDEFA14ASyndax Pharmaceuticals IncSNDXApr 30

    Additional proxy materials

19. ROUTINEDEF 14ASyndax Pharmaceuticals IncSNDXApr 30

    Proxy statement

20. NOTABLE10-QSyndax Pharmaceuticals IncSNDXApr 30

    Quarterly report

21. ROUTINE8-KSyndax Pharmaceuticals IncSNDXApr 30

    Current report

22. ROUTINESCHEDULE 13GSyndax Pharmaceuticals IncSNDXApr 30

    Ownership stake disclosure by VANGUARD CAPITAL MANAGEMENT LLC

    VANGUARD CAPITAL MANAGEMENT LLC, filed by

23. ROUTINESCHEDULE 13G/ASyndax Pharmaceuticals IncSNDXMar 27

    Ownership stake disclosure by VANGUARD GROUP INC (amended)

    VANGUARD GROUP INC, filed by

24. ROUTINES-8Syndax Pharmaceuticals IncSNDXFeb 26

    Employee stock plan registration

25. NOTABLE10-KSyndax Pharmaceuticals IncSNDXFeb 26

    Annual report

26. ROUTINE8-KSyndax Pharmaceuticals IncSNDXFeb 26

    Current report

27. ROUTINE4Syndax Pharmaceuticals IncSNDXFeb 10

    2 insider filings

    Michael A Metzger, insider filing for SNDX

    Show all 2

    • 4Insider filing for SNDXFeb 10
    • 4Insider filing for SNDXFeb 10

    Michael A Metzger, reporting

28. ROUTINE144Syndax Pharmaceuticals IncSNDXFeb 9

    2 Form 144 notices

    Michael A Metzger, planned sale of SNDX shares

    Show all 2

    • 144Planned insider sale of SNDX sharesFeb 9
    • 144Planned insider sale of SNDX sharesFeb 9

    Michael A Metzger, reporting

29. ROUTINESCHEDULE 13GSyndax Pharmaceuticals IncSNDXFeb 9

    Ownership stake disclosure by STATE STREET CORP

    STATE STREET CORP, filed by

30. ROUTINE4Syndax Pharmaceuticals IncSNDXFeb 6

    9 insider filings

    Michael A Metzger, insider filing for SNDX

    Show all 9

    • 4Insider filing for SNDXFeb 6
    • 4Insider filing for SNDXFeb 6
    • 4Insider filing for SNDXFeb 6
    • 4Insider filing for SNDXFeb 6
    • 4Insider filing for SNDXFeb 6
    • 4Insider filing for SNDXFeb 6
    • 4Insider filing for SNDXFeb 6
    • 4Insider filing for SNDXFeb 6
    • 4Insider filing for SNDXFeb 6

    Michael A Metzger, reporting

31. ROUTINE144Syndax Pharmaceuticals IncSNDXFeb 6

    2 Form 144 notices

    Michael A Metzger, planned sale of SNDX shares

    Show all 2

    • 144Planned insider sale of SNDX sharesFeb 6
    • 144Planned insider sale of SNDX sharesFeb 6

    Michael A Metzger, reporting

32. ROUTINESCHEDULE 13G/ASyndax Pharmaceuticals IncSNDXJan 30

    Ownership stake disclosure by VANGUARD GROUP INC (amended)

    VANGUARD GROUP INC, filed by

33. ROUTINE8-KSyndax Pharmaceuticals IncSNDXJan 12

    Current report

34. ROUTINE8-KSyndax Pharmaceuticals IncSNDXDec 19, 2025

    Current report

35. ROUTINE4Syndax Pharmaceuticals IncSNDXDec 1, 2025

    Keith A. Goldan, insider filing for SNDX

    Keith A. Goldan, reporting

36. NOTABLE10-QSyndax Pharmaceuticals IncNov 3, 2025

    Quarterly report

37. ROUTINE8-KSyndax Pharmaceuticals IncNov 3, 2025

    Current report

Older filings on EDGAR